{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.0",
    "document_metadata": {
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "Tiernan2016",
      "version": "1.0.0",
      "authors": "Rana Aldisi",
      "description": ""
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/7e4be528f12abd28be768b62402fba6e083eaf9e/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
      "PUBCHEM": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/knowledge/hbp_knowledge/tiernan2016.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau aggregates",
      "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau antibody, TNT1",
      "id": "c796a83d992a31f44fd416a82c553ea69886271a8874826c38794337517edd3598e1d7600b8d88fccbe5d7f4b89aa744c88b53c8ef340e5a8aba804b3feda576"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau dimers",
      "id": "a45c996c1e47893f23cae5bb6f2ded7768e3bfe470c1f55b4cd44433533d0f473b8d3df10019d54856e0009a2eb16c32b4ee0a46310e69b709cd023655e77f1d"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau oligomers",
      "id": "d4ceff8aa5a5d05770aaa29b828d003b85d64e7e5337c6624b7c5a84111845897462b589e7b259b0eed6bcfc63f34cdaf1f9b988c788804799aea026d8731d98"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "TOC1",
      "id": "ca4bed88212c59b16a3d939b6c1a7112e87f5bca22e342ace6e89c004a9a34fc8a22a22010319b00cef2616e545301afa10f90ce5eb2420cd5eadb1a3d368141"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "anterograde axonal protein transport",
      "id": "8f3fac5a50a55c8d864f449be04fec4b2e6e93b959efd6c6f00c776203619d6d0aeac89e4478d892fd7c7391b455e698e63afe4817e761faae3d76149891ef00"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "retrograde axonal protein transport",
      "id": "6bea952f92c4e84e44e4aa46ae11fd038e397f0c64414ba3d02f553a3e6192a4339d5384567f9fc2f7b9979be7f4c960652dcf9907c36c5a87a2c8f383a39ff9"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "Tau aggregates",
          "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "f71ce3ef78c9a77b61670564e22a167419c0351b5a3cb3046057d00cb053857f5eb68562717e4d3fade408e729cccd84c9884727d1f414cbdf7f1e82e737f863"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "Tau aggregates",
          "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "variants": [
            {
              "kind": "hgvs",
              "identifier": "p.S422E"
            }
          ],
          "id": "51a623d35c37b482fdb490007497173f4a17b5dd988db033dba6f8b9ecd43efcb3be98205a409d3e69029bf325d52465d9b1baab8bdbedf3ade19049b75754ea"
        }
      ],
      "id": "bdb78b5fa0505499c045e2171179e484c71e07c849f61a74dbbe77102bed1ff20e7c65187c4dd8a3d83963250b1a63934db413f730dd09ba64207e9d24c12293"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "Tau antibody, TNT1",
          "id": "c796a83d992a31f44fd416a82c553ea69886271a8874826c38794337517edd3598e1d7600b8d88fccbe5d7f4b89aa744c88b53c8ef340e5a8aba804b3feda576"
        },
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "TOC1",
          "id": "ca4bed88212c59b16a3d939b6c1a7112e87f5bca22e342ace6e89c004a9a34fc8a22a22010319b00cef2616e545301afa10f90ce5eb2420cd5eadb1a3d368141"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "variants": [
            {
              "kind": "pmod",
              "identifier": {
                "namespace": "bel",
                "name": "Ph"
              }
            },
            {
              "kind": "hgvs",
              "identifier": "p.S422E"
            }
          ],
          "id": "5f9b1d87c6074f2184be9054194e05be32f520a4e0bae05f4c337ab48a00f2aedf9f9ce0486bd9be25d1f99a1d45e21c3403833cb80e56823b9999f72e9f8202"
        }
      ],
      "id": "c48e9a38c1dad44073e9195157c4211ce8881d92ea6b5639be61d0fe35db58228a13cebe67abbd78ec5c3f0d727c45562e9f65fb25b53a1397a9e28057cfdc7c"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        },
        {
          "kind": "hgvs",
          "identifier": "p.S422E"
        }
      ],
      "id": "5f9b1d87c6074f2184be9054194e05be32f520a4e0bae05f4c337ab48a00f2aedf9f9ce0486bd9be25d1f99a1d45e21c3403833cb80e56823b9999f72e9f8202"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.S422E"
        }
      ],
      "id": "51a623d35c37b482fdb490007497173f4a17b5dd988db033dba6f8b9ecd43efcb3be98205a409d3e69029bf325d52465d9b1baab8bdbedf3ade19049b75754ea"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Alzheimer Disease",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541"
    }
  ],
  "links": [
    {
      "line": 89,
      "relation": "increases",
      "evidence": "However, the rate of polymerization (kapparent) did not differ between hT40 tau and S422E tau. At 360 min, a similar intensity of light scattering was observed for hT40 (122.5 ± 1.2) and S422E tau (134.5±1.7) indicating that the extent of aggregate formation was comparable between these two proteins. ThS fluorescence, measured at 360min, alsowas comparable between hT40 aggregates (946.4 ± 73.8) and S422E aggregates (927.9 ± 63.7).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 10,
      "target": 0,
      "key": "1122758b051e8e7b3d276c8d3c2146e8d12501ac4f7a8f60d340a25ffa761a521963c7ed006c56047e9c0dfa0cc0c3e2a59b1a3c188996960393d8cbefb754f5"
    },
    {
      "relation": "hasVariant",
      "source": 10,
      "target": 13,
      "key": "c199f1fea298e80c1d5d02368c1ba094ec7e061c6419a3d245f65a88065154c2a74bd07471afb8f0c2a59e68a9ebbfb8cdb514195311c829d2efe4d301093927"
    },
    {
      "line": 100,
      "relation": "increases",
      "evidence": "For both tau constructs, there were significantly more oligomer-type aggregates than short or long filaments formed, but no significant difference between the numbers of short or long filament (Fig. 2E; F(2,12) = 86.64, p b 0.0001). S422E did not differ significantly from hT40 in the number of oligomers, short filaments, or long filaments formed (F(1,12) = 0.05, p = 0.83).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 10,
      "target": 3,
      "key": "c9dc8c4fe9b67e9c0466dc348bcaebbf3dec746959711b611c497d2fc2348f12e908f79cb65acf8cfb7d1fc573ab60d3edcd5a59625ed6b7ba8003a5b4ac2871"
    },
    {
      "line": 136,
      "relation": "causesNoChange",
      "evidence": "As previously reported, perfusion of hT40 monomer had no effect on the rate of anterograde FAT in the squid axoplasm (Fig. 5A), whereas perfusion of hT40 aggregates significantly inhibited anterograde FAT as compared to hT40 monomer (Fig. 5B; Fig. 6A; p = 0.003) (LaPointe et al., 2009b). Neither hT40 monomers nor hT40 aggregates altered the rate of retrograde FAT (Fig. 5A, B; Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 10,
      "target": 5,
      "key": "e4b0e5b508608c644b28cdc4d07354fc6b7550dec1aa4e5ba711dd0cca5a42d60031f2240cef3424fdcbcfbdc512e7bcb8f6785a69144ed416a0d705b9ae5582"
    },
    {
      "line": 138,
      "relation": "causesNoChange",
      "evidence": "As previously reported, perfusion of hT40 monomer had no effect on the rate of anterograde FAT in the squid axoplasm (Fig. 5A), whereas perfusion of hT40 aggregates significantly inhibited anterograde FAT as compared to hT40 monomer (Fig. 5B; Fig. 6A; p = 0.003) (LaPointe et al., 2009b). Neither hT40 monomers nor hT40 aggregates altered the rate of retrograde FAT (Fig. 5A, B; Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 10,
      "target": 6,
      "key": "860444f4aba5fd3445c4b332bfdf44bce731223fa5e833a3f6aca929ef50338ef8542a48d14f154a409aa20bc821065f8ca3a0dd9919dc6360fb4da0d0563356"
    },
    {
      "relation": "hasVariant",
      "source": 10,
      "target": 11,
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48"
    },
    {
      "relation": "hasVariant",
      "source": 10,
      "target": 12,
      "key": "237bf868bfa62a59ff6d176f3cd694d5bf3c44f07c5ab646e57f290cf49448745336d0336438828e28b7087dcf6068fd7d61148ac2de92347c01fd95601aad31"
    },
    {
      "line": 174,
      "relation": "positiveCorrelation",
      "evidence": "The amount of total tau captured with pS422 (detected with the pan-tau antibody, Tau5) was significantly higher in AD compared to control (Fig. 7E; t10 = 6.07, p = 0.0001). The level of pS422 tau that also contained PAD exposed tau (i.e., TNT1 reactive) was significantly higher in AD compared to control (Fig. 7F; t10 = 2.31, p = 0.0435). Similarly, the level of pS422 tau that also contained an oligomeric conformation (i.e., TOC1 reactive) was significantly higher in AD compared to control (Fig. 7G; t10 = 1.51, p = 0.0029).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 0,
      "target": 14,
      "key": "787759b1c7d21af735d42aefc51a22ff8018e4fc6862f3c4611e20842de2f6d44d46afc646188af639c094c34e8f66bf9c0eb01751105ffa48dd8a59c4c70939"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "However, the rate of polymerization (kapparent) did not differ between hT40 tau and S422E tau. At 360 min, a similar intensity of light scattering was observed for hT40 (122.5 ± 1.2) and S422E tau (134.5±1.7) indicating that the extent of aggregate formation was comparable between these two proteins. ThS fluorescence, measured at 360min, alsowas comparable between hT40 aggregates (946.4 ± 73.8) and S422E aggregates (927.9 ± 63.7).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 13,
      "target": 0,
      "key": "d292c07e48082f3752b6f6d90c0b5a0061dcc8b0196bab9ffddd032aafabf5cff748e8fdb6d8b4520b0d31f8d8ee5b84b406e455d6b37aada4bd76ac0c5a9c62"
    },
    {
      "line": 101,
      "relation": "increases",
      "evidence": "For both tau constructs, there were significantly more oligomer-type aggregates than short or long filaments formed, but no significant difference between the numbers of short or long filament (Fig. 2E; F(2,12) = 86.64, p b 0.0001). S422E did not differ significantly from hT40 in the number of oligomers, short filaments, or long filaments formed (F(1,12) = 0.05, p = 0.83).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 13,
      "target": 3,
      "key": "d5189b13989c0fef55351dea7b869ae20fbdf8d2e5e6a63cdedf0bc017b56196e887da8d8d81af2f579f6dfe930889b3dca22fa097b9be3dbc4da0bd600c68ba"
    },
    {
      "line": 149,
      "relation": "decreases",
      "evidence": "In contrast to hT40 monomer, perfusion of S422E monomer selectively inhibited anterograde transport (Fig. 5C; Fig. 6A; p = 0.028), but not retrograde FAT. Surprisingly, aggregated S422E significantly inhibited both anterograde and retrograde FAT rates (Fig. 5D; Fig. 6A, B) compared to S422E monomer (anterograde, p = 0.012; retrograde, p = 0.002) and hT40 aggregates (retrograde only, p = 0.019).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 13,
      "target": 5,
      "key": "7ee69b2f815e72fb8805290945e58e613e3fbedb0eef96794965e57a1dd9f5e89ddd6bf0e77fd24b1aa929f0ca6f0cff49c427a6126eac56397dbb4eedf56171"
    },
    {
      "line": 151,
      "relation": "causesNoChange",
      "evidence": "In contrast to hT40 monomer, perfusion of S422E monomer selectively inhibited anterograde transport (Fig. 5C; Fig. 6A; p = 0.028), but not retrograde FAT. Surprisingly, aggregated S422E significantly inhibited both anterograde and retrograde FAT rates (Fig. 5D; Fig. 6A, B) compared to S422E monomer (anterograde, p = 0.012; retrograde, p = 0.002) and hT40 aggregates (retrograde only, p = 0.019).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 13,
      "target": 6,
      "key": "f20b63b510b2074532fdc22ca89e1188f991a28fa2cc344190bc5dc78e9fc42c3ddd156b56c70f8a540b7bad1e46124864592bfc6f6f1e24e8d698becb5948c9"
    },
    {
      "relation": "hasComponent",
      "source": 8,
      "target": 0,
      "key": "851f4a4aa2656df97cc8e3ad3bf63f2a82971e944464de87932c37d4ba5e86792130edb8d3ff4a4155a924a3d033198d8eadaa1f1caa152e63f42c2a5cf58812"
    },
    {
      "relation": "hasComponent",
      "source": 8,
      "target": 13,
      "key": "0723983c8b0fdd258a2bf61a5e1f983764dbb8849a39a92f10b949000921c89aab5b660e5379758e2313610865f0bd1f448825cfcc228efb4cb7b986c9fcc9e6"
    },
    {
      "line": 112,
      "relation": "increases",
      "evidence": "Compared to monomers, aggregation significantly increased PAD exposure for both hT40 and S422E samples (Fig. 3B; F(1,12) = 685.8, p b 0.0001), as indicated by increased TNT1 reactivity. Aggregation also significantly increased oligomer formation (TOC1 reactivity) compared to monomers in both hT40 and S422E samples (Fig. 3C; F(1,12) = 109.3, p b 0.0001).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 8,
      "target": 3,
      "key": "7d9f9076acfcf3636da75b1214db55bc2c166e4ccf1860ea46a27da1735b624ef49d2f74c700564f68cea0545833f3e900a367cc1eb17cc13ee113e5d1521624"
    },
    {
      "line": 124,
      "relation": "increases",
      "evidence": "In contrast, aggregation of either hT40 or S422E significantly increased the amount of SDS-stable dimers at 180 kDa (Fig. 4C; F(1,12) = 110.0; p b 0.0001), as compared to the levels of these species in the respective monomer samples. Furthermore, S422E aggregation significantly increased the amount of SDS-stable dimers compared to hT40 aggregation (p = 0.03).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 8,
      "target": 2,
      "key": "e9ecb897e5236d5d21059ce6cb35b2e0aa8611edd75c590c9c92aa734f4b761ffcdb5b3faceb5c557b1a8153cd6dede97db6a54a3db4e0851d87065a56c66622"
    },
    {
      "line": 148,
      "relation": "decreases",
      "evidence": "In contrast to hT40 monomer, perfusion of S422E monomer selectively inhibited anterograde transport (Fig. 5C; Fig. 6A; p = 0.028), but not retrograde FAT. Surprisingly, aggregated S422E significantly inhibited both anterograde and retrograde FAT rates (Fig. 5D; Fig. 6A, B) compared to S422E monomer (anterograde, p = 0.012; retrograde, p = 0.002) and hT40 aggregates (retrograde only, p = 0.019).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 8,
      "target": 5,
      "key": "8b70a48bd12948fb429f31c810a7a76445063363fcf7335d795fce9f5bbb66e5b3bd8695c0cc27f803fbfd59ac12cf1a771a7b7b33047859e5abcab359ca7495"
    },
    {
      "line": 150,
      "relation": "decreases",
      "evidence": "In contrast to hT40 monomer, perfusion of S422E monomer selectively inhibited anterograde transport (Fig. 5C; Fig. 6A; p = 0.028), but not retrograde FAT. Surprisingly, aggregated S422E significantly inhibited both anterograde and retrograde FAT rates (Fig. 5D; Fig. 6A, B) compared to S422E monomer (anterograde, p = 0.012; retrograde, p = 0.002) and hT40 aggregates (retrograde only, p = 0.019).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 8,
      "target": 6,
      "key": "0eb91aa4c0a36b740f59e76107dd5b7f1a74da3da775ebd3e509931d53110887c3a7f7d846f59f258bd092817eb0566cc0f55945c277df90fe95cbf47a9965a8"
    },
    {
      "relation": "hasComponent",
      "source": 7,
      "target": 0,
      "key": "7e130cfe6124124023c6023f314b25f1b5feffbbaf161a5682ca378b78775fa76191cf4730160af3cbce8833d9f7694ea495d99f19edaba04d876b53305df7f5"
    },
    {
      "relation": "hasComponent",
      "source": 7,
      "target": 10,
      "key": "94e6df16d4dff8ee07b957027bf8e5d07f5acd2a431780d5598ef05a0e14919d46bfa65642e161ac8d41da9decacfbc5cafdae73aed9541960e0ae2082841df6"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "Compared to monomers, aggregation significantly increased PAD exposure for both hT40 and S422E samples (Fig. 3B; F(1,12) = 685.8, p b 0.0001), as indicated by increased TNT1 reactivity. Aggregation also significantly increased oligomer formation (TOC1 reactivity) compared to monomers in both hT40 and S422E samples (Fig. 3C; F(1,12) = 109.3, p b 0.0001).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 7,
      "target": 3,
      "key": "8967c8f2161d63707858012bca9b1cf9e7564e5adea6b855cda8c5117a9e8ee8d6c9d52ede7fbc5a3d889b5fa33d5c570b44331580025ee0214c0fd732eeb78f"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": "In contrast, aggregation of either hT40 or S422E significantly increased the amount of SDS-stable dimers at 180 kDa (Fig. 4C; F(1,12) = 110.0; p b 0.0001), as compared to the levels of these species in the respective monomer samples. Furthermore, S422E aggregation significantly increased the amount of SDS-stable dimers compared to hT40 aggregation (p = 0.03).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 7,
      "target": 2,
      "key": "03581bc0d1b55ca7c955192aab4bc91c98cf8ce158a130593e2faf995b8cdb74eba0e9dcb2e81e51e39f7c91b71e923f0b8c587cd2ba293aa33410dfccc0c314"
    },
    {
      "line": 135,
      "relation": "decreases",
      "evidence": "As previously reported, perfusion of hT40 monomer had no effect on the rate of anterograde FAT in the squid axoplasm (Fig. 5A), whereas perfusion of hT40 aggregates significantly inhibited anterograde FAT as compared to hT40 monomer (Fig. 5B; Fig. 6A; p = 0.003) (LaPointe et al., 2009b). Neither hT40 monomers nor hT40 aggregates altered the rate of retrograde FAT (Fig. 5A, B; Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 7,
      "target": 5,
      "key": "e716e1d23d5ba6355ca259f0d0487ef9c15e8dd933bd48f461e7bb89da27db5d521bcb7abf7a19c40490c4f74ec0c9ab323e340ccd00d644b844db8365dd73ff"
    },
    {
      "line": 137,
      "relation": "causesNoChange",
      "evidence": "As previously reported, perfusion of hT40 monomer had no effect on the rate of anterograde FAT in the squid axoplasm (Fig. 5A), whereas perfusion of hT40 aggregates significantly inhibited anterograde FAT as compared to hT40 monomer (Fig. 5B; Fig. 6A; p = 0.003) (LaPointe et al., 2009b). Neither hT40 monomers nor hT40 aggregates altered the rate of retrograde FAT (Fig. 5A, B; Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 7,
      "target": 6,
      "key": "880f4c2e50aa14c985416a46aa3f052c9d62f3de25a2076b71718b087e0da3380e12ef28bb166545253039c556aff29afb137539e062e061535296de40ccdc2b"
    },
    {
      "line": 160,
      "relation": "increases",
      "evidence": "Staining in fixed tissue sections confirmed several previous reports (Kanaan et al., 2016; Mufson et al., 2014; Patterson et al., 2011a) that pS422 (Fig. 7A) extensively colocalizes with TNT1 (Fig. 7B) and TOC1 (Fig. 7C) in both control and AD brains, despite the relatively sparse appearance of tau pathology in the temporal cortices of control cases (data not shown).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "object": {
        "location": {
          "namespace": "MESH",
          "name": "Brain"
        }
      },
      "source": 11,
      "target": 9,
      "key": "b82a5acf9c4a67b78d27cbc27d88fe7f7f5c5c94353ca57f6ea81a164ac00287d3688c7bea0eced53b273766c374d6c37bdba611824af335c315f86ab48078d1"
    },
    {
      "line": 173,
      "relation": "positiveCorrelation",
      "evidence": "The amount of total tau captured with pS422 (detected with the pan-tau antibody, Tau5) was significantly higher in AD compared to control (Fig. 7E; t10 = 6.07, p = 0.0001). The level of pS422 tau that also contained PAD exposed tau (i.e., TNT1 reactive) was significantly higher in AD compared to control (Fig. 7F; t10 = 2.31, p = 0.0435). Similarly, the level of pS422 tau that also contained an oligomeric conformation (i.e., TOC1 reactive) was significantly higher in AD compared to control (Fig. 7G; t10 = 1.51, p = 0.0029).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 11,
      "target": 14,
      "key": "d1f77439141c50deccd1f77d9d3e3c5c2a27db03d9a5766df18cda442e70182428a665a9c0ebee5d0017a59db2b58815580c70bdaadfb9dec6a8863f228e2cbb"
    },
    {
      "relation": "hasComponent",
      "source": 9,
      "target": 1,
      "key": "35c06592edb41061bee9de20759cddca972da0673b4f258187749b5dc10735d401933e0cc42203ef048cc18c796a09cfb08ca125d3a26fecd02d9b95efaa8e5a"
    },
    {
      "relation": "hasComponent",
      "source": 9,
      "target": 4,
      "key": "355cf9bb1139a40a5e57fe0f25341bfdba8e8d5b5c22c7177472c854d7ae66e335a120a0a2606d9f9c5a1babace89436ecf0abd941b927737e51723ffbac9c19"
    },
    {
      "relation": "hasComponent",
      "source": 9,
      "target": 12,
      "key": "c1658a60a6caf8968228459ecffd9e89523260256023277d9ee49f05c0b734e19a55a7e9634b220462b4c6dec5dd8b71be1ddf74e92ab0ff01046404a2f8ac2e"
    },
    {
      "line": 173,
      "relation": "positiveCorrelation",
      "evidence": "The amount of total tau captured with pS422 (detected with the pan-tau antibody, Tau5) was significantly higher in AD compared to control (Fig. 7E; t10 = 6.07, p = 0.0001). The level of pS422 tau that also contained PAD exposed tau (i.e., TNT1 reactive) was significantly higher in AD compared to control (Fig. 7F; t10 = 2.31, p = 0.0435). Similarly, the level of pS422 tau that also contained an oligomeric conformation (i.e., TOC1 reactive) was significantly higher in AD compared to control (Fig. 7G; t10 = 1.51, p = 0.0029).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 14,
      "target": 11,
      "key": "45b7f87aeb45358d2ddcc96ed88b35db9ea1953f803814f970336395f0c6f8bef645f333bc23121b0399a38c805a4aee7c3802e3ac7d4f887d68d915676d867b"
    },
    {
      "line": 174,
      "relation": "positiveCorrelation",
      "evidence": "The amount of total tau captured with pS422 (detected with the pan-tau antibody, Tau5) was significantly higher in AD compared to control (Fig. 7E; t10 = 6.07, p = 0.0001). The level of pS422 tau that also contained PAD exposed tau (i.e., TNT1 reactive) was significantly higher in AD compared to control (Fig. 7F; t10 = 2.31, p = 0.0435). Similarly, the level of pS422 tau that also contained an oligomeric conformation (i.e., TOC1 reactive) was significantly higher in AD compared to control (Fig. 7G; t10 = 1.51, p = 0.0029).",
      "citation": {
        "type": "PubMed",
        "reference": "27373205"
      },
      "source": 14,
      "target": 0,
      "key": "3de349cdd10ae9a1e9334d631b9c775b3c236063745cb3e0fb9d3954b38aec6527cfdd3f6862a1a0a9662dc7963da868101b38b0285456b11dceb5a624cd755c"
    }
  ]
}